For citations:
Stoma I.O., Voropaev E.V., Mikhailova E.I., Los D.M., Osipkina O.V., Braga A.Yu., Kovalev A.A., Molchanova A.V., Trofimova N.V., Pershenkova O.S., Yaroshevich B.S., Mirge M.N. Safety Assessment of Inactivated Whole Virion Booster Vaccine against the SARS-CoV-2 Virus (BelCovidVac) in Immunized Study Subjects aged 18 to 60 Years (day 28). Epidemiology and Vaccinal Prevention. 2024;23(3):107-119. (In Russ.) https://doi.org/10.31631/2073-3046-2024-23-3-107-119
Email this article 